Drug allergy assessment at a university hospital and clinic

American Journal of Health-System Pharmacy

Volumn 53, Issue 24, 1996, Pages 2970-2974

  Pilzer, Jacqueline D ^a,b   Burke, Timothy G ^b,c   Mutnick, Alan H ^b,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UIHC   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Administration; Allergies; Ambulatory care; Antibiotics; Clinical pharmacists; Costs; Drugs, adverse reactions; Economics; Interventions; Opiates; Patient information; Patients; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARDIOVASCULAR AGENT; DIPHENHYDRAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; SULFONAMIDE;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030453786     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.24.2970     Document Type: Article

References (9)

1. Redlmeier DA, Sox HC. Role of skin testing for penicillin allergy. Arch Intern Med. 1990; 150:1929-46.
2. Lin RY. A perspective on penicillin allergy. Arch Intern Med. 1992; 152:930-7.
3. Shepherd GM. Allergy to beta-lactam antibiotics. Immunol Clin North Am. 1991; 11:611-33.
4. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
5. Absy M. Antibiotic allergy: inaccurate history taking in a teaching hospital. South Med J. 1994; 87:805-7.
6. Glover R, Trottier L. Pharmacy involvement in the evaluation of drug allergies. Can J Hosp Pharm. 1979; 30:38-44.
7. Tripp DM, Brown GR. Pharmacist assessment of drug allergies. Am J Hasp Pharm. 1993; 50:95-8.
8. Mutnick AH, Sterba KJ, Peroutka JA et al. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm. In press.
9. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.